Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$26.13 - $33.94 $192,369 - $249,866
-7,362 Reduced 40.29%
10,912 $314,000
Q3 2023

Oct 31, 2023

SELL
$32.09 - $37.51 $58,339 - $68,193
-1,818 Reduced 9.05%
18,274 $606,000
Q2 2023

Aug 04, 2023

BUY
$36.12 - $41.79 $129,201 - $149,482
3,577 Added 21.66%
20,092 $736,000
Q1 2023

Apr 25, 2023

BUY
$39.39 - $51.28 $393,269 - $511,979
9,984 Added 152.87%
16,515 $673,000
Q4 2022

Aug 27, 2024

BUY
$41.75 - $54.5 $951,148 - $1.24 Million
22,782 New
22,782 $1.17 Billion
Q4 2022

Feb 03, 2023

SELL
$41.75 - $54.5 $1.22 Million - $1.6 Million
-29,311 Reduced 81.78%
6,531 $334,000
Q3 2022

Aug 26, 2024

BUY
$43.76 - $53.42 $109,137 - $133,229
2,494 Added 7.65%
35,086 $1.54 Billion
Q3 2022

Oct 17, 2022

BUY
$43.76 - $53.42 $85,288 - $104,115
1,949 Added 5.75%
35,842 $1.57 Million
Q2 2022

Aug 26, 2024

BUY
$46.53 - $55.17 $1.52 Million - $1.8 Million
32,592 New
32,592 $1.71 Billion
Q2 2022

Jul 20, 2022

BUY
$46.53 - $55.17 $98,690 - $117,015
2,121 Added 6.68%
33,893 $1.78 Million
Q1 2022

Aug 26, 2024

BUY
$45.75 - $56.69 $1.4 Million - $1.74 Million
30,673 New
30,673 $1.59 Billion
Q1 2022

Jul 19, 2022

BUY
$45.75 - $56.69 $274 - $340
6 Added 0.02%
31,772 $1.65 Million
Q1 2022

Apr 18, 2022

SELL
$45.75 - $56.69 $3.11 Million - $3.85 Million
-67,891 Reduced 68.12%
31,766 $1.65 Million
Q4 2021

Aug 22, 2024

BUY
$41.32 - $61.25 $1.32 Million - $1.96 Million
32,062 New
32,062 $1.89 Billion
Q4 2021

Jan 31, 2022

BUY
$41.32 - $61.25 $4.12 Million - $6.1 Million
99,657 New
99,657 $5.88 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $167B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Peterson Financial Group, Inc. Portfolio

Follow Peterson Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peterson Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Peterson Financial Group, Inc. with notifications on news.